Kon Tum Sugar JSC (HNX:KTS)

Intercept Pharmaceuticals Cash Flow Statement

Financials in millions VND. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Net Income	50,726	30,913	38,197	8,010	5,672	1,982
Other Operating Activities	105,946	-629.25	-46,545	3,493	10,625	-16,287
Operating Cash Flow	156,671	30,284	-8,348	11,503	16,297	-14,304
Operating Cash Flow Growth	-	-	-	-29.42%	-	-
Capital Expenditures	-46,726	-18,518	-3,656	-1,515	-	-4,055
Sale of Property, Plant & Equipment	109.09	109.09	-	-	-	-
Other Investing Activities	2,716	2,430	3,715	11,937	5.13	10.42
Investing Cash Flow	-61,900	-33,979	59.58	10,422	5.13	-4,045
Long-Term Debt Issued	-	269,619	283,808	185,830	116,127	146,896
Total Debt Issued	173,207	269,619	283,808	185,830	116,127	146,896
Long-Term Debt Repaid	-	-264,753	-273,368	-208,474	-131,263	-155,981
Total Debt Repaid	-247,852	-264,753	-273,368	-208,474	-131,263	-155,981
Net Debt Issued (Repaid)	-74,645	4,865	10,440	-22,644	-15,136	-9,086
Common Dividends Paid	-	-4,056	-	-	-	-
Financing Cash Flow	-74,645	809.13	10,440	-22,644	-15,136	-9,086
Net Cash Flow	20,126	-2,886	2,151	-719.37	1,166	-27,435
Free Cash Flow	109,946	11,766	-12,004	9,988	16,297	-18,360
Free Cash Flow Growth	-	-	-	-38.71%	-	-
Free Cash Flow Margin	30.60%	4.22%	-2.19%	5.66%	6.57%	-11.98%
Free Cash Flow Per Share	21684.15	2320.55	-2367.67	1970.17	3215.33	-3260.41
Cash Interest Paid	9,092	12,777	21,981	23,366	15,778	15,413
Cash Income Tax Paid	572.17	1,830	2,528	1,606	445.84	247.36
Levered Free Cash Flow	-48,391	-7,863	-33,255	-1,434	-32,461	-56,562
Unlevered Free Cash Flow	-36,568	5,359	-19,114	10,790	-19,582	-49,185
Change in Net Working Capital	33,286	8,655	52,168	913.39	32,922	53,641

Source: S&P Global Market Intelligence. Standard template. Financial Sources.